CABG Clinical Trial - Transfer of Cardioprotection During RIPC

Status Completed

Clinical Trial Summary

Remote ischemic preconditioning (RIPC) with transient upper limb ischemia/reperfusion provides peri-operative myocardial protection, is safe and improves prognosis in patients undergoing elective CABG surgery. The signal transfer from limb to heart is unknown. Thus, the aim of this study is to identify the pathways which transfer the cardioprotective signal from the ischemic/reperfused extremity to the heart in humans undergoing surgical coronary revascularization.

Clinical Trial Description

The investigators will obtain arterial blood samples before skin incision and 1-72 h after the remote ischemic preconditioning protocol and analyze them biochemically. The investigators focus on those ligands that have been previously implicated in conditioning protocols at any organ. In addition, the investigators will use a bioassay system, consisting of a Langendorff-perfused isolated heart with coronary occlusion/reperfusion and infarct size by TTC staining as endpoint, and then expose this bioassay system to arterial plasma obtained after the remote ischemic preconditioning stimulus or placebo. This approach will allow us to further characterize any potential transfer signal candidate with a pharmacological antagonist approach. The investigators will also obtain human atrial appendages after the remote ischemic preconditioning protocol or placebo and before patients were connected to the extracorporeal circulation. Contractile function of isolated trabeculae and vasomotor function of isolated arterial vessels will be analyzed in a bioassay system. ;

Study Design

Related Conditions & MeSH terms

CABG

Clinical Trial Details

NCT number	NCT01956708
Study type	Interventional
Source	University Hospital, Essen
Contact
Status	Completed
Phase	N/A
Start date	September 2013
Completion date	April 20, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01928745` - Experimental Determination of Atot en Ka in the Critically Ill	N/A
Active, not recruiting	`NCT00966654` - Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery	Phase 2
Completed	`NCT00524901` - Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia	Phase 2
Completed	`NCT01282671` - Effects of Deep Breathing Exercises Two Months After Cardiac Surgery	Phase 2
Completed	`NCT03050489` - Assessment of Myocardial Ischemic-Reperfusion Injury During Off- and On- Pump CABG
Recruiting	`NCT06124937` - Empagliflozin to Prevent Post-Operative Atrial Fibrillation	Phase 3
Completed	`NCT00269243` - Management With Accupril Post Bypass Graft	Phase 4
Recruiting	`NCT03139929` - Measurement of MSFP and Stressed Volume With CardioQ+®
Active, not recruiting	`NCT03424941` - The TransCatheter Valve and Vessels Trial	N/A
Completed	`NCT06317363` - Effects of Acapella VS CHEST Physiotherapy in Post-Operative CABG Patients	N/A
Completed	`NCT05023083` - Cross Cultural Adaptation of Functional Status Questionnaire in Urdu Language in CABG Patients
Completed	`NCT03800264` - Bisoprolol Versus Corticosteroid and Bisoprolol Combination for Prophylaxis Against Atrial Fibrillation After on Pump Coronary Artery Bypass Surgery	Phase 4
Completed	`NCT05285865` - Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients	N/A
Not yet recruiting	`NCT06173609` - Long LIMA Patch on Left Anterior Descending Coronary Artery in CABG
Not yet recruiting	`NCT06238011` - Dexmedetomidine vs Control on Attenuation Hemodynamic Response to Noxious Stimuli in CABG Surgical Patients	N/A
Active, not recruiting	`NCT06127147` - High-intensity Inspiratory Muscle Training as a Pre-cardiac Rehabilitation in Heart Disease	N/A
Recruiting	`NCT06029556` - Effects of Early Mobility Protocols in Cardiac ICU	N/A
Enrolling by invitation	`NCT01205620` - IRB-HSR# 15084 A Prospective, Unblinded, Controlled Study to Evaluate the Effect of the ITPR in Patients Undergoing OPCAB Surgery	Phase 2